Canada inks deal with Novavax to manufacture coronavirus vaccine in Montreal
February 3, 2021
As soon as it’s up and operating, the Montreal plant will have the ability to produce about 2 million doses month-to-month, CBC Information mentioned, although it can take months to get there. After the vaccine approvals, which may take a number of weeks, the NRC should end establishing the power, then have it licensed to make the vaccines.